Navigation Links
Botulinum Toxin Share Higher in Canada Than in the US

Millennium Research Group's Marketrack Results find Botulinum Toxin has

Higher 2007 Market Share in Canada than in the US

WALTHAM, Mass., Jan. 31 /PRNewswire/ -- Millennium Research Group's (MRG's) Facial Aesthetic Marketrack results indicate that revenue and usage share of botulinum toxin (as a percentage of all injectables) was consistently higher in Canada than in the United States throughout 2007. With the revenue share of botulinum toxin nearly 10% higher in Canada, botulinum toxin was preferred more in Canada than it was in the US in 2007.

In Canada, dermal fillers, including hyaluronic acid (HA), collagen, and particle and polymer fillers, had a usage share approximately equal to that of botulinum toxin. In contrast, the US injectable market was dominated by dermal fillers, which represented approximately two-thirds of total facial injectables units used. Throughout 2007, the Canadian market was driven by widespread public awareness of botulinum toxin cosmetic and other advertised dermal fillers, including HA, collagen, and particle and polymer fillers. As a result, well-informed patients have been asking for injectables such as Allergan's Botox by name. Media exposure will likely not only encourage first-time patients to try Botox injections, but will also encourage existing patients to continue with their treatments.

"An increase in marketing on Allergan's behalf has had a big effect on this increase in Canada," says Jennifer Thomas, Senior Analyst at Millennium Research Group. "Media such as magazines and television shows frequently profile cosmetic procedures, which has led to increased public awareness and widespread acceptance of various less invasive aesthetic treatments."

MRG provides a number of products focused on the global facial aesthetics market. For ongoing quarterly tracking of market shares by brand, MRG offers its Marketrack service, which tracks facial aesthetic products -- such as botulinum toxin, HA, collagen, and particle and polymer injectables -- in the US and Canada. This project has been expanded to include tracking of breast implant procedures in US plastic surgery facilities. Besides market share, this service also provides brand-level usage (units, average selling price, and revenue), detailed procedure numbers, and practitioner practice information.

For in-depth analysis and five-year growth forecasts, MRG offers its Global Markets for Facial Aesthetics report series, which includes individual reports on the US, Europe, Asia Pacific, Canada, Brazil, and Mexico. Companies covered by MRG facial aesthetics market research include Allergan, Solstice Neurosciences, Ipsen, Q-Med, Medicis, Bioform Medical Inc., Dermik Labs, Sanofi-Aventis, Mentor, Teoxane, Lifecell, Fascia Biosystems, and Artes Medical.

Millennium Research Group will be attending the 66th Annual American Academy of Dermatology Meeting in San Antonio, Texas on February 2-4. Come to booth #309 to discover how we can help you meet your needs.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Environmental Toxin Collects in Breast Milk
2. UIC chemists characterize Alzheimers neurotoxin structure
3. MyoMed Launches Flash Virtual Tour of Toxin-Free Pain Relief
4. Laser Energetics Provides Joint Venture Update to Shareholders
5. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
6. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Assurant Board of Directors Declares Quarterly Dividend of $0.12 per Share
9. Moog Reports 14% Increase in Earnings Per Share
10. Rigel Announces Offering of 4,000,000 Shares of Common Stock
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
(Date:11/29/2015)... Ca (PRWEB) , ... November 29, 2015 , ... Khanna ... American Board of Ophthalmology on November 25th 2015. Peer Certification by the ... field of his specialty. Certification in Ophthalmology is first obtained after the completion of ...
(Date:11/29/2015)... ... November 29, 2015 , ... Doctors who missed a case of mesothelioma ... signs of mesothelioma and push for a diagnosis, especially in people exposed to asbestos. ... here to read it now. , Researchers at Gifu Prefectural Tajimi Hospital ...
(Date:11/29/2015)... Chicago, IL (PRWEB) , ... November 29, 2015 , ... ... website, In addition starting on Black Friday Target is offering a “Buy ... only. This is a rare opportunity to purchase IguanaMed at a discounted price. ...
(Date:11/28/2015)... ... November 28, 2015 , ... StatRad ... has added Chris Hafey and Claude Hooton to its board of directors. The ... North America (RSNA) 2015 Annual Meeting and continues to strategically transform its focus ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Trying to ... has created the COUCH BUDDY. "I conceived of this design due to personal experience ... for couch users. It promotes relaxation and convenience, as well as increases support. It ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... , Nov. 29, 2015 CIVCO ... guidance technology at the Radiological Society of ... Chicago November 29 – ... is designed to offer customers unrivaled versatility, enhanced ... --> ...
(Date:11/27/2015)... November 27, 2015 Ein ... fortgeschrittenem Krebs.   --> Ein neuer ... Krebs.   --> Ein neuer ... Krebs.   Clinical Cancer Research ... Clinical Cancer Research vom 6. November 2015 ...
(Date:11/26/2015)... , November 27, 2015 ... --> --> ... emergency response system (PERS) market ... for 5 years with APAC ... expected to see a high ...
Breaking Medicine Technology: